Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 7, 2015; 21(13): 3912-3920
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3912
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3912
Table 1 Study population characteristics n (%)
| n | 358 |
| Gender (M/F) | 281 (78.5)/77 (21.5) |
| Age at LT (yr, mean ± SD) | 52 ± 9 |
| Donor age (yr, mean ± SD) | 53 ± 17 |
| HCV Genotype | |
| 1 | 212 (59.2) |
| 2 | 48 (13.4) |
| 3 | 57 (15.9) |
| 4 | 41 (11.5) |
| Immunosuppression | |
| Cyclosporine | 269 (75.1) |
| Tacrolimus | 83 (23.2) |
| Other regimens | 6 (1.7) |
| Antiviral therapy after LT | |
| Treated | 150 (41.9) |
| Untreated | 208 (58.1) |
- Citation: Gitto S, Belli LS, Vukotic R, Lorenzini S, Airoldi A, Cicero AFG, Vangeli M, Brodosi L, Panno AM, Di Donato R, Cescon M, Grazi GL, De Carlis L, Pinna AD, Bernardi M, Andreone P. Hepatitis C virus recurrence after liver transplantation: A 10-year evaluation. World J Gastroenterol 2015; 21(13): 3912-3920
- URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3912.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i13.3912